Patients and partners join forces to tackle fear of cancer recurrence
NCT ID NCT07234656
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at fear of cancer recurrence in people who had surgery for kidney cancer and their partners. Researchers are working with patients to create better ways to ask about and measure this fear. The goal is to improve follow-up care by understanding what matters most to patients and their loved ones.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better understand and address fear of cancer recurrence in kidney cancer survivors and their partners, improving follow-up care.
- What could go wrong
- This is an early, small observational study (105 participants) focused on developing and testing questionnaires, not testing a treatment. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FEAR OF CANCER RECURRENCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aalborg University Hospital
RECRUITINGAalborg, 9000, Denmark
-
Aarhus University Hospital
RECRUITINGAarhus, 8200, Denmark
-
Gødstrup Hospital
RECRUITINGHerning, 7400, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Facing the fear: can talk therapy help couples live beyond cancer?
- New imaging agent aims to spot Hard-to-Find kidney cancer spread
- Triple therapy takes on rare, aggressive kidney cancer
- Nerve block may slash opioid use after kidney surgery
- New imaging registry aims to sharpen cancer treatment precision
- Gene therapy safety check: 400 cancer patients monitored for years